Sherwood Forest slips on capital spend
FINANCE: Slippage on capital expenditure due to the delay on the renal scheme remains outside of the 25 per cent tolerance level that Monitor applies to capital spend variances.
Continue reading this article – simply subscribe below
Subscribing takes two minutes and you’ll immediately have full access to hsj.co.uk, plus the HSJ magazine delivered every week.
HSJ Subscribers:
If you are a Health Service Journal subscriber please sign in with your email address and click submit:
Not yet a subscriber?
Sign up today for immediate access to hsj.co.uk and Health Service Journal magazine
Alternatively, try our 14-day free trial subscription
